Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty
You'll soon see Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty.
Think of it as a more powerful cousin to clopidogrel (Plavix).
Effient is more effective than clopidogrel for preventing MIs after angioplasty...but it also causes more bleeding.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote